ADMA BIOLOGICS, INC. Prepaid Expense and Other Assets, Current
ADMA BIOLOGICS, INC. (ADMA) had Prepaid Expense and Other Assets, Current of $14.64 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-05
- 2026-06-30: Prepaid Expense and Other Assets, Current $14.64M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $15.06M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $7.46M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $6.93M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $14.64M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $15.06M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $7.46M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $6.93M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $8.09M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $8.59M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $8.03M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $9.54M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $5.52M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.74M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $5.33M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $5.11M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $5.22M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $4.38M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $5.09M 10-K · filed 2024-02-28 | $5.10M 10-K · filed 2023-03-23 |
| 2022-09-30 | $5.37M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $5.40M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $5.52M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $4.34M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $5.86M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $5.70M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $5.80M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $3.05M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $3.79M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $4.69M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $4.86M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $2.53M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $1.72M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $1.60M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $2.05M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $1.77M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $2.13M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $2.43M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $2.70M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $1.23M 10-K · filed 2019-03-13 | $2.05M 10-K · filed 2018-03-29 |
| 2017-09-30 | $2.08M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $2.41M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $746.85K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $313.91K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $481.66K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $638.06K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $744.91K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $111.03K 10-K · filed 2017-02-24 | |
| 2015-09-30 | $266.78K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $399.33K 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $613.36K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $143.59K 10-K · filed 2016-03-23 | |
| 2014-09-30 | $285.66K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $394.89K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $597.60K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $298.73K 10-K · filed 2015-03-09 | |
| 2013-09-30 | $223.42K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $366.96K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $651.44K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $107.76K 10-K · filed 2014-03-28 | |
| 2012-09-30 | $189.60K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $308.16K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $428.46K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $59.24K 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |